Dossier
Lyfgenia
Coverage of Lyfgenia in the Nexus archive.
- Gene therapy cures metro New Orleans man of sickle cell, clears path for dream of becoming pilot
Daniel Cressy, a 23-year-old from Metairie, became the first patient in the Gulf South to be functionally cured of sickle cell disease through gene editing. The treatment, using FDA-approved therapies Casgevy and Lyfgenia, involved a $2.2 million process including stem cell extraction and chemotherapy, with Cressy now experiencing normal hemoglobin and no sickling cells.